X-ray Structures and Mechanism of the Human Serotonin Transporter

Overview

Journal Nature

Specialty Science

Date 2016 Apr 7

PMID 27049939

Citations 315

Authors

Jonathan A Coleman

Evan M Green

Eric Gouaux

Affiliations

Soon will be listed here.

Abstract

The serotonin transporter (SERT) terminates serotonergic signalling through the sodium- and chloride-dependent reuptake of neurotransmitter into presynaptic neurons. SERT is a target for antidepressant and psychostimulant drugs, which block reuptake and prolong neurotransmitter signalling. Here we report X-ray crystallographic structures of human SERT at 3.15 Å resolution bound to the antidepressants (S)-citalopram or paroxetine. Antidepressants lock SERT in an outward-open conformation by lodging in the central binding site, located between transmembrane helices 1, 3, 6, 8 and 10, directly blocking serotonin binding. We further identify the location of an allosteric site in the complex as residing at the periphery of the extracellular vestibule, interposed between extracellular loops 4 and 6 and transmembrane helices 1, 6, 10 and 11. Occupancy of the allosteric site sterically hinders ligand unbinding from the central site, providing an explanation for the action of (S)-citalopram as an allosteric ligand. These structures define the mechanism of antidepressant action in SERT, and provide blueprints for future drug design.

Citing Articles

Fluorescent PyrAte-()-citalopram conjugates enable imaging of the serotonin transporter in living tissue.

Belleza O, Saridakis I, Singer N, Westergaard X, Armentia Matheu S, Lemmerer M Chem Sci. 2025; .

PMID: 40070471 PMC: 11891579. DOI: 10.1039/d4sc06949h.

Modulation of the human GlyT1 by clinical drugs and cholesterol.

Li N, Wei Y, Li R, Meng Y, Zhao J, Bai Q Nat Commun. 2025; 16(1):2412.

PMID: 40069141 PMC: 11897355. DOI: 10.1038/s41467-025-57613-z.

Structure of mitochondrial pyruvate carrier and its inhibition mechanism.

He Z, Zhang J, Xu Y, Fine E, Suomivuori C, Dror R Nature. 2025; .

PMID: 40044865 DOI: 10.1038/s41586-025-08667-y.

Uncovering the Elusive Structures and Mechanisms of Prevalent Antidepressants.

Lin J, Bu G, Unge J, Gonen T Adv Ther (Weinh). 2025; 7(9).

PMID: 40012744 PMC: 11864751. DOI: 10.1002/adtp.202400117.

Solute carriers: The gatekeepers of metabolism.

Khan A, Liu Y, Gad M, Kenny T, Birsoy K Cell. 2025; 188(4):869-884.

PMID: 39983672 PMC: 11875512. DOI: 10.1016/j.cell.2025.01.015.

References

Andersen J, Stuhr-Hansen N, Zachariassen L, Toubro S, Hansen S, Eildal J . Molecular determinants for selective recognition of antidepressants in the human serotonin and norepinephrine transporters. Proc Natl Acad Sci U S A. 2011; 108(29):12137-42. PMC: 3141962. DOI: 10.1073/pnas.1103060108. View

Broer S, Gether U . The solute carrier 6 family of transporters. Br J Pharmacol. 2012; 167(2):256-78. PMC: 3481037. DOI: 10.1111/j.1476-5381.2012.01975.x. View

Barker E, Perlman M, Adkins E, Houlihan W, Pristupa Z, Niznik H . High affinity recognition of serotonin transporter antagonists defined by species-scanning mutagenesis. An aromatic residue in transmembrane domain I dictates species-selective recognition of citalopram and mazindol. J Biol Chem. 1998; 273(31):19459-68. DOI: 10.1074/jbc.273.31.19459. View

Ramamoorthy S, Bauman A, Moore K, Han H, Chang A, Ganapathy V . Antidepressant- and cocaine-sensitive human serotonin transporter: molecular cloning, expression, and chromosomal localization. Proc Natl Acad Sci U S A. 1993; 90(6):2542-6. PMC: 46124. DOI: 10.1073/pnas.90.6.2542. View

Forrest L, Tavoulari S, Zhang Y, Rudnick G, Honig B . Identification of a chloride ion binding site in Na+/Cl -dependent transporters. Proc Natl Acad Sci U S A. 2007; 104(31):12761-6. PMC: 1937540. DOI: 10.1073/pnas.0705600104. View

Singh S, Yamashita A, Gouaux E . Antidepressant binding site in a bacterial homologue of neurotransmitter transporters. Nature. 2007; 448(7156):952-6. DOI: 10.1038/nature06038. View

Glowinski J, Axelrod J . INHIBITION OF UPTAKE OF TRITIATED-NORADRENALINE IN THE INTACT RAT BRAIN BY IMIPRAMINE AND STRUCTURALLY RELATED COMPOUNDS. Nature. 1964; 204:1318-9. DOI: 10.1038/2041318a0. View

Krishnamurthy H, Gouaux E . X-ray structures of LeuT in substrate-free outward-open and apo inward-open states. Nature. 2012; 481(7382):469-74. PMC: 3306218. DOI: 10.1038/nature10737. View

Scanlon S, Williams D, Schloss P . Membrane cholesterol modulates serotonin transporter activity. Biochemistry. 2001; 40(35):10507-13. DOI: 10.1021/bi010730z. View

10.

McCoy A, Grosse-Kunstleve R, Adams P, Winn M, Storoni L, Read R . Phaser crystallographic software. J Appl Crystallogr. 2009; 40(Pt 4):658-674. PMC: 2483472. DOI: 10.1107/S0021889807021206. View

11.

Carlsson A, Fuxe K, Ungerstedt U . The effect of imipramine on central 5-hydroxytryptamine neurons. J Pharm Pharmacol. 1968; 20(2):150-1. DOI: 10.1111/j.2042-7158.1968.tb09706.x. View

12.

Green E, Coleman J, Gouaux E . Thermostabilization of the Human Serotonin Transporter in an Antidepressant-Bound Conformation. PLoS One. 2015; 10(12):e0145688. PMC: 4687910. DOI: 10.1371/journal.pone.0145688. View

13.

Singh S, Piscitelli C, Yamashita A, Gouaux E . A competitive inhibitor traps LeuT in an open-to-out conformation. Science. 2008; 322(5908):1655-61. PMC: 2832577. DOI: 10.1126/science.1166777. View

14.

KYTE J, Doolittle R . A simple method for displaying the hydropathic character of a protein. J Mol Biol. 1982; 157(1):105-32. DOI: 10.1016/0022-2836(82)90515-0. View

15.

Afonine P, Grosse-Kunstleve R, Echols N, Headd J, Moriarty N, Mustyakimov M . Towards automated crystallographic structure refinement with phenix.refine. Acta Crystallogr D Biol Crystallogr. 2012; 68(Pt 4):352-67. PMC: 3322595. DOI: 10.1107/S0907444912001308. View

16.

Penmatsa A, Wang K, Gouaux E . X-ray structure of dopamine transporter elucidates antidepressant mechanism. Nature. 2013; 503(7474):85-90. PMC: 3904663. DOI: 10.1038/nature12533. View

17.

Wennogle L, Meyerson L . Serotonin modulates the dissociation of [3H]imipramine from human platelet recognition sites. Eur J Pharmacol. 1982; 86(2):303-7. DOI: 10.1016/0014-2999(82)90333-8. View

18.

Zhou Z, Zhen J, Karpowich N, Law C, Reith M, Wang D . Antidepressant specificity of serotonin transporter suggested by three LeuT-SSRI structures. Nat Struct Mol Biol. 2009; 16(6):652-7. PMC: 2758934. DOI: 10.1038/nsmb.1602. View

19.

Sorensen L, Andersen J, Thomsen M, Hansen S, Zhao X, Sandelin A . Interaction of antidepressants with the serotonin and norepinephrine transporters: mutational studies of the S1 substrate binding pocket. J Biol Chem. 2012; 287(52):43694-707. PMC: 3527955. DOI: 10.1074/jbc.M112.342212. View

20.

Andersen J, Olsen L, Hansen K, Taboureau O, Jorgensen F, Jorgensen A . Mutational mapping and modeling of the binding site for (S)-citalopram in the human serotonin transporter. J Biol Chem. 2009; 285(3):2051-63. PMC: 2804362. DOI: 10.1074/jbc.M109.072587. View